Dr. Marks, Clinical Professor of Health Promotion, has expertise in several areas: rheumatology; orthopedics; rehabilitation; health promotion and prevention; obesity studies. She has served as the Director (2005 - present) of the Center for Health Promotion, School of Health and Behavioral Sciences, City University of New York, York College—a non-profit Public Health Education Center with a 20 year history of serving the local community. She is adjunct Full Professor, Columbia University, Teachers College, Health and Behavioral Studies. She has published widely in many realms including obesity issues.

Research Interest

Dr. Ying Qu is a multi-disciplinary scientist, currently works in Exagen Diagnostics Inc., USA. She received her BS and MS in Chemistry from Lanzhou University, China and PhD in Neuroscience from Catholic University of Leuven, Belgium. Postdoctoral training from National Institute on Aging/National Institutes of Health, USA. She has been involved in a drug discovery and development program in Pharmaceutical Research and Development of Johnson & Johnson and Amylin Pharmaceuticals Inc. in USA. She has published over 30 peer-reviewed papers, 40 abstracts and 2 book chapters in both fields of Neuropharmacology and Analytical Chemistry. Her main research interests have been focusing on the studies of autoimmune disease utilizing modern analytical technologies to monitor biomarkers and therapeutics for disease diagnosis, treatment prediction and prognostication.

Research Interest

Dr. Yibing Li, the founder and medical director of CPMR (Center for Pain Management and Rehab, S.C and Midwest Joint Pain Institute, SC), is an interventional physiatrist and a Regenerative Medicine specialist. She is American board certified in both Pain Medicine and Physical Medicine & Rehabilitation. She is also the first certified physician in central Illinois to perform painless neurosensory testing with Neural-Scan, the most cutting edge technology for pain fiber diagnosis. She earned her BS/MD degree at Shenyang Medical College in China. After she graduated from Brody School of Medicine, East Carolina University as a medical intern, she completed her PM&&R (Physical Medicine & Rehabilitation) residency at renowned Washington University School of Medicine/Barnes-Jewish Hospital in St. Louis, MO, USA. She worked as an interventional physiatrist at Unity point Methodist Medical Center prior to opening her own private practice in Peoria, IL. She has special clinical interests in the most advanced, cutting edge regenerative therapies, such as stem cell therapy, PRP (platelet rich plasma), PRF (platelet rich fibrin) bio-cellular injections and prolotherapy, to help people naturally restore functions and heal the root causes of the pain from sport injuries, arthritis, without surgery or downtime. She has extensive experiences in performing electro diagnostic studies and interventional pain management procedures. She works very closely with primary care physicians, orthopedic surgeons, neurosurgeons, chiropractors, and other healthcare professionals in the area.

Research Interest

Research Interest

Dr. Isabel M. McFarlane, MD, is Board Certifiedin Internal Medicine and Rheumatology. She obtained her medical degree from the Catholic University of Guayaquil, Ecuador. She is currently a Clinical Assistant Professor at SUNY- Downstate Medical Center in Brooklyn, NY. Shecompleted her Internal Medicine Residency and Rheumatology Fellowship training at SUNY Downstate Medical Center.Her research on heart rate variability in lupus erythematosus patients won her the Henry Christian Award by the American Federation for Clinical Research.At Kings County Hospital Center,she served in several leadership positions including Senior Associate Directorship and as a Physician Advisor to Hospital Quality Reporting to major regulatory agencies including State Department of Health, American Heart Association and Centers for Medicare and Medicaid Services.She provides high quality care that is compassionate, culturally sensitive and evidence-based to patients with various types of rheumatologic disorders including, Rheumatoid arthritis, Systemic Lupus Erythematosus, Gout, Osteoarthritis and several other other diseases

Research Interest

Research Interest

Research Interest

Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013. He graduated in medicine at the University of Bologna in 1968. He completed his residence programme in otolaryngology and subsequently in pathology. He worked at the ENT Department of Padua University from 1970 to 1997. Since 2009 he is the Coordinator of the International Head Neck Scientific Group. Professor Ferlito has collaborated in writing articles, editorials, commentaries, consensus statements, letters to the editor, special issues, book chapters and books with 638 international experts. He has edited a three-volume book entitled Cancer of the Larynx (CRC Press, Boca Raton, 1985) and three other books entitled Neoplasms of the Larynx (Churchill Livingstone, Edinburgh, 1993), Surgical Pathology of Laryngeal Neoplasms (Chapman and Hall, London, 1996) and Diseases of the Larynx (Arnold, London, 2000), and co-authored two books entitled Granulomas and Neoplasms of the Larynx together with Professor Imrich Friedmann (Churchill Livingstone, Edinburgh, 1988) and Surgery for Cancer of the Larynx and Related Structures together with Dr. Carl E. Silver (Saunders, Philadelphia, 1996). He is editor with Dr. Marvin P. Fried of the third edition of a two-volume book entitled The Larynx (Plural Publishing, San Diego, 2009) and with Drs. K. Thomas Robbins and Carl E. Silver of the book entitled Neck Dissection - Management of Regional Disease in Head and Neck Cancer.

Research Interest

Medical director at catanzaro university hospital, department of neurosurgery, catanzaro, italy. Head of neurophysiopathology unit at catanzaro university hospital, department of neurosurgery, catanzaro, italy.

Research Interest

Giuseppe Maurizio Campo was born in Novara di Sicilia (ME), Italy, September the 16th, 1963. He followed doctoral Degree Courses in Biological Sciences at the University of Messina from 1987 to 1998 he attended the Institute of Pharmacology, School of Medicine at the University of Messina. In years 1990-1992 he worked as scientific adviser of the FIDIA Research Laboratories of Abano Terme and the Cifa-gesco Consortium of Rome for the study and development of new drugs. In the October 1992 he obtained the Specialization Degree in "Biochemistry and Clinical Chemistry" at the University of. Messina. In the year 1993 he obtained a postdoctoral scholarship of the CNR for a stage at the Department of Medical Laboratory Sciences and Technology, at the Karolinska Institute, Huddinge University Hospital, Stockholm. Giuseppe Maurizio Campo has received his PhD in “Experimental medicine” in the University of Messina during the period of 1994-1998. Currently, he is working as Associate Professor of Biochemistry in the University of Messina. He have successfully completed his Administrative responsibilities. His research has included more than 150 impacted publications. Expert Review of Molecular diagnosis. He is a member of “Science Advisory Board”, USA – Reviewer member of French National Research Agency (ANR), France - Reviewer member of National Science Centre (NCN), Poland.

Research Interest

Pr Christian Jorgensen was born in 1961 in Copenhagen, Denmark. He was trained in Paris XII University medical faculty as specialist in Therapeutics and Rheumatology. He is head of research unit UMR NSERM-1183 (�Cellules Souches, Plasticit� Cellulaire, M�decine R�g�n�ratrice & Immunoth�rapies"�) IRMB (Montpellier � France). He leads the Institute for regenerative institute & biotherapies (IRMB) and is in charge of Biotherapy department at university hospital Montpellier. Since the beginning of the unit in 2007, he animates this group composed by 150 permanent senior researchers and engineers dedicated to therapeutic innovation in the field of arthritis and cartilage regeneration. On the other hand, C Jorgensen clinical interest is in stem cell base therapies, clinical immunology and rheumatology. He is head of the clinical unit, "clinical immunology and immuno-therapy�, University Hospital Lapeyronie (Montpellier). He leads the clinical unit with 20 beds dedicated to biotherapy applied to Rheumatoid Arthritis and other autoimmune diseases. He is PI of phase 1-2 trials dedicated to osteoarthritis therapy through autologous adipose derived stem cells approved by ANSM. He is the coordinator of ECELLFRANCE, a national platform dedicated to stem cell based therapy supported by �Investissement d�avenir�. He is expert for biologics at French National Authority or Health (HAS), where he was former member of Transparency Comity (reimbursement comity at HAS). He is actually member of national scientific council of Inserm and former member scientific council of University of Montpellier. He is in charge of FHU REGENHAB, interdisciplinary federation of medical science and technology dedicated to improve musculo-skeletal function. C Jorgensen has published extensively (over 500 publications in the field of Immunology and stem cell therapy applied for rheumatic diseases, h-Index 67), and has a strong track record for competitive research grant from EU and ANR. He has coordinated a program of 2004-2007 FP6 integrated project Genostem �Adult mesenchymal stem cells engineering for connective tissue disorders�. He is also principal investigator in the Integrated Project 6th FP-healing Autocure: Post-genomic Approaches for inflammatory rheumatic disease� and WP Leader in FP7 BTCure and REGENAR, leading to the development of Improved therapy in arthritis. Finally, today he coordinates the clinical trial within H2020 ADIPOA2 large scale project focusing on adipose-derived mesenchymal stem cells in osteoarthritis therapy. Christian Jorgensen is member of the EULAR, the French Society of Rheumatology, the American Society for Rheumatology (ACR) and former vice president of the �Soci�t� Francophone pour la th�rapie g�nique et cellulaire� (SFTCG) and he is corresponding author for the faculty �F1000 Medicine�. C Jorgensen is heading the EULAR gene and cell therapy study group, and coordinating the French GDR �groupe de recherche GRIMIT� dedicated to biomaterial applied to stem cells. C Jorgensen is a first class professor in medicine in the Faculty of Medicine Montpellier-Nimes (responsible teacher of MT11 therapeutic). He is also responsible for the Master "Evaluation & methodology of therapeutic trials�.

Research Interest

Born in 1962 year in Gevgelija, R.Macedonia. Elementary and middle school finished in Gevgelija. Graduated medical faculty in Skopje 1987 year. Practice exam take 1989 y. Became a specialist physiatrist 1989 year. Defense magisterial study in 2002 year at Medical faculty in Skopje, and defense doctoral study in 2010 at Medical faculty Nis, R. Serbia. She was in professional improvement in R. Germany in 1997 and 2000 year, in area of geriatric rehabilitation and post surgical treatment rehabilitation. Visiting study in ISICO-Italy. ?an.2016.

Research Interest

Research Interest